Syros Pharmaceuticals Inc (SYRS)
5.00
+0.03
(+0.60%)
USD |
NASDAQ |
May 28, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Cash from Operations (Quarterly): -31.10M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -31.10M |
| December 31, 2023 | -18.56M |
| September 30, 2023 | -31.86M |
| June 30, 2023 | -22.39M |
| March 31, 2023 | -36.90M |
| December 31, 2022 | -31.08M |
| September 30, 2022 | -35.79M |
| June 30, 2022 | -26.18M |
| March 31, 2022 | -30.02M |
| December 31, 2021 | -22.97M |
| September 30, 2021 | -28.13M |
| June 30, 2021 | -26.45M |
| March 31, 2021 | -21.99M |
| December 31, 2020 | -29.92M |
| September 30, 2020 | -15.26M |
| June 30, 2020 | -12.43M |
| March 31, 2020 | 0.246M |
| December 31, 2019 | -10.60M |
| September 30, 2019 | -11.22M |
| Date | Value |
|---|---|
| June 30, 2019 | -18.10M |
| March 31, 2019 | -20.33M |
| December 31, 2018 | -13.81M |
| September 30, 2018 | -10.02M |
| June 30, 2018 | -14.08M |
| March 31, 2018 | -2.40M |
| December 31, 2017 | -10.57M |
| September 30, 2017 | -9.532M |
| June 30, 2017 | -11.81M |
| March 31, 2017 | -12.82M |
| December 31, 2016 | -9.596M |
| September 30, 2016 | -9.171M |
| June 30, 2016 | -11.15M |
| March 31, 2016 | -10.62M |
| December 31, 2015 | -8.201M |
| September 30, 2015 | -5.464M |
| June 30, 2015 | -6.096M |
| March 31, 2015 | -3.269M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.90M
Minimum
Mar 2023
0.246M
Maximum
Mar 2020
-23.04M
Average
-24.57M
Median
Cash from Operations (Quarterly) Benchmarks
| PDS Biotechnology Corp | -9.938M |
| PAVmed Inc | -13.11M |
| Moderna Inc | -989.00M |
| Altimmune Inc | -16.36M |
| iBio Inc | -3.654M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -24.64M |
| Cash from Financing (Quarterly) | -0.265M |
| Free Cash Flow | -103.90M |
| Free Cash Flow Per Share (Quarterly) | -0.7978 |
| Free Cash Flow Yield | -66.80% |